Vitamin B Antagonists
نویسنده
چکیده
V ITAMIN B11 is a catalyst of considerable biological imimportance. Studies during time past 15 years have estai)lished a key role for thus vitanlin in protein and amiiino aci(1 mmletabohismll and, sommiewhat less firmly, in fat imletai)ohism. It would seemil, therefore, timat suitable antagonists to thus vitaillmn mllighmt be of timerapeutic inml)ortance. We are actually ill a utmost curious situation with respect to vitamimin B5 anti its antagonists-so tilat I trust time present discussion is not a mere repetition, for yet another vitamin, of furthier cxammmples of cimemical alteration of time vitamin molecule. iro i I ing substances antagonistic to time vitamin, somm e of which may possess clinical value. To possess tilerapeutic significance, sucim antagonists must have properties otimer timan mere antagonism. Time properties of time vitamin B11 group and time nature of tile antagonists have been recently and adequately reviewed.m234 I simall, timerefore, concentrate my attention upon some newer aspects of the proi)lem of vitamin B6 antagonists, particularly timose having some t imerapeut ic implications. Time field for antagonists in time vitamin B6 group, witim its mi any related mllembers, would seem to be wide enougim. I shall use the term vitammmin B5 to designate all active members, and time specific comm mmion naimmes for particular memmmhers of time grOut). As illustrated in Figure 1, at present vitamin B6 comprises pyri(ioxme, yridoxamlline, pyridoxal and their respeetive l)imospimates. Timem’e doubtless exist in nature and certainly imave been prepared in time laboratory several substances wilich, upon breakdown, yield vitamllin B6, as, for example, time pyrithoxyhidene amilines, time pyridoxyl amllines, and the pyridoxyiamino acids.#{176}’T THE ACTIVE FORM
منابع مشابه
New modalities for treatment of diabetic nephropathy: a mini review
Background and aims: Diabetic nephropathy (DN) is the most common cause of end-stage renal failure which could increase the risk of cardiovascular disease and morbidity and mortality in patients. The aim of this study was to investigate new modalities for treatment of diabetic nephropathy. Methods:This study was a mini-review research to investigate drugs that are used for DN treatment. Resul...
متن کاملComparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
BACKGROUND Vitamin K antagonists, the current standard treatment for prophylaxis against stroke and systemic embolism in patients with atrial fibrillation, require regular monitoring and dose adjustment; an unmonitored, fixed-dose anticoagulant regimen would be preferable. The aim of this randomised, open-label non-inferiority trial was to compare the efficacy and safety of idraparinux with vit...
متن کاملDietary Supplement Fact Sheet: Vitamin B12 — Health Professional Fact Sheet
Malouf R, Areosa Sastre A. Vitamin B12 for cognition. Cochrane Database Syst Rev 2003;(3):CD004326. [PubMed abstract] 79. Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of health elderly and demented people. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD004514. [PubMed abstract] 80. Lukaski HC. Vitamin and mineral status: effects on physical pe...
متن کاملEFFECTS OF DOPAMINE RECEPTOR AGONISTS AND ANTAGONISTS ON BACLOFEN-INDUCED ANTINOCICEPTION IN FORM ALIN TEST
In this study, the influence of dopamine receptor agonists and antagonists on antinociception induced by bac10fen has been examined in the formalin test. The GABA-B agonist bac10fen induced antinociception in both phases of the formalin test in mice. The dopamine receptor agonists SKF 38393 and quinpirole also induced antinociception in both phases of the test. SKF 38393 but not quinpirole ...
متن کاملNutrition and heart failure: impact of drug therapies and management strategies.
Nutrition impairment commonly occurs in patients with heart failure and affects disease progression. Vitamin and mineral deficiencies are associated with early mortality, particularly in patients classified as cachectic. Guideline-based therapies approved for heart failure, such as loop diuretics, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, aldosterone antagonist...
متن کامل